![]() |
Name |
paecilin F
|
Molecular Formula | C33H34O15 | |
IUPAC Name* |
methyl5-hydroxy-6-[5-hydroxy-2-methoxycarbonyl-2-(3-methyl-5-oxooxolan-2-yl)-4-oxo-3H-chromen-8-yl]-2-(1-hydroxy-4-methoxy-2-methyl-4-oxobutyl)-4-oxo-3H-chromene-2-carboxylate
|
|
SMILES |
COC(=O)CC(C)C(O)C1(C(=O)OC)CC(=O)c2c(ccc(-c3ccc(O)c4c3OC(C(=O)OC)(C3OC(=O)CC3C)CC4=O)c2O)O1
|
|
InChI |
InChI=1S/C33H34O15/c1-14(10-22(37)43-3)28(40)32(30(41)44-4)12-20(36)25-21(47-32)9-7-16(26(25)39)17-6-8-18(34)24-19(35)13-33(31(42)45-5,48-27(17)24)29-15(2)11-23(38)46-29/h6-9,14-15,28-29,34,39-40H,10-13H2,1-5H3/t14-,15-,28+,29+,32-,33-/m0/s1
|
|
InChIKey |
SAFOXXOSNQBKTL-MMJMNZOWSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 670.62 | ALogp: | 2.0 |
HBD: | 3 | HBA: | 15 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 218.5 | Aromatic Rings: | 5 |
Heavy Atoms: | 48 | QED Weighted: | 0.272 |
Caco-2 Permeability: | -5.271 | MDCK Permeability: | 0.00002120 |
Pgp-inhibitor: | 0.558 | Pgp-substrate: | 0.04 |
Human Intestinal Absorption (HIA): | 0.88 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.932 |
Blood-Brain-Barrier Penetration (BBB): | 0.03 | Plasma Protein Binding (PPB): | 79.64% |
Volume Distribution (VD): | 0.42 | Fu: | 11.30% |
CYP1A2-inhibitor: | 0.023 | CYP1A2-substrate: | 0.636 |
CYP2C19-inhibitor: | 0.077 | CYP2C19-substrate: | 0.103 |
CYP2C9-inhibitor: | 0.37 | CYP2C9-substrate: | 0.542 |
CYP2D6-inhibitor: | 0.022 | CYP2D6-substrate: | 0.168 |
CYP3A4-inhibitor: | 0.899 | CYP3A4-substrate: | 0.58 |
Clearance (CL): | 13.324 | Half-life (T1/2): | 0.145 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.85 |
Drug-inuced Liver Injury (DILI): | 0.971 | AMES Toxicity: | 0.024 |
Rat Oral Acute Toxicity: | 0.909 | Maximum Recommended Daily Dose: | 0.035 |
Skin Sensitization: | 0.008 | Carcinogencity: | 0.077 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.005 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005729 | ![]() |
0.884 | D0T5XN | ![]() |
0.272 | ||
ENC005732 | ![]() |
0.884 | D07IPB | ![]() |
0.264 | ||
ENC005735 | ![]() |
0.884 | D01UBX | ![]() |
0.257 | ||
ENC005736 | ![]() |
0.814 | D01XWG | ![]() |
0.253 | ||
ENC005734 | ![]() |
0.797 | D0Q0PR | ![]() |
0.251 | ||
ENC003346 | ![]() |
0.738 | D0C9XJ | ![]() |
0.249 | ||
ENC005728 | ![]() |
0.692 | D07VLY | ![]() |
0.249 | ||
ENC003347 | ![]() |
0.671 | D01XDL | ![]() |
0.246 | ||
ENC005730 | ![]() |
0.660 | D0T8EH | ![]() |
0.238 | ||
ENC003348 | ![]() |
0.645 | D08LTU | ![]() |
0.226 |